Cargando…

Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial

INTRODUCTION: Fatigue is one of the most disabling symptoms associated with fibromyalgia that greatly impacts quality of life. Fatigue was assessed as a secondary objective in a 2-phase, 24-week study in outpatients with American College of Rheumatology-defined fibromyalgia. METHODS: Patients were r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arnold, Lesley M, Wang, Fujun, Ahl, Jonna, Gaynor, Paula J, Wohlreich, Madelaine M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218901/ https://www.ncbi.nlm.nih.gov/pubmed/21668963 http://dx.doi.org/10.1186/ar3359

Ejemplares similares

Safety and efficacy of duloxetine treatment in older and younger patients with osteoarthritis knee pain: a post hoc, subgroup analysis of two randomized, placebo-controlled trials
por: Micca, Joseph L, et al.
Publicado: (2013)

Effect of duloxetine in patients with fibromyalgia: tiredness subgroups
por: Bradley, Laurence A, et al.
Publicado: (2010)

Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials
por: Choy, Ernest H. S., et al.
Publicado: (2009)

Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial
por: Upadhyaya, Himanshu P., et al.
Publicado: (2019)

Duloxetine in the treatment of Major Depressive Disorder: A comparison of efficacy in patients with and without melancholic features
por: Mallinckrodt, Craig H, et al.
Publicado: (2005)

Changes in energy during treatment of depression: an analysis of duloxetine in double-blind placebo-controlled trials
por: Harada, E, et al.
Publicado: (2015)

Duloxetine for the long-term treatment of Major Depressive Disorder in patients aged 65 and older: an open-label study
por: Wohlreich, Madelaine M, et al.
Publicado: (2004)

Duloxetine for the management of fibromyalgia syndrome
por: Scholz, Beth A, et al.
Publicado: (2009)

The efficacy of duloxetine: A comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials
por: Mallinckrodt, Craig H, et al.
Publicado: (2004)

Is duloxetine's effect on painful physical symptoms in depression an indirect result of improvement of depressive symptoms? Pooled analyses of three randomized controlled trials
por: Harada, Eiji, et al.
Publicado: (2015)

Predictors of duloxetine adherence and persistence in patients with fibromyalgia
por: Cui, Zhanglin, et al.
Publicado: (2012)

A six-month double-blind, placebo-controlled, randomized clinical trial of duloxetine for the treatment of fibromyalgia
por: Chappell, Amy S, et al.
Publicado: (2009)

A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients
por: Murakami, Masato, et al.
Publicado: (2015)

New treatment options for fibromyalgia: critical appraisal of duloxetine
por: Üçeyler, Nurcan, et al.
Publicado: (2008)

Efficacy and Safety of Duloxetine in Patients with Chronic Low Back Pain Who Used versus Did Not Use Concomitant Nonsteroidal Anti-Inflammatory Drugs or Acetaminophen: A Post Hoc Pooled Analysis of 2 Randomized, Placebo-Controlled Trials
por: Skljarevski, Vladimir, et al.
Publicado: (2012)

Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial
por: Alaka, Karla J, et al.
Publicado: (2014)

Observational study of upper gastrointestinal tract bleeding events in patients taking duloxetine and nonsteroidal anti-inflammatory drugs: a case-control analysis
por: Li, Hu, et al.
Publicado: (2014)

The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports
por: Perahia, David G, et al.
Publicado: (2013)

Duloxetine in the treatment of chronic pain due to fibromyalgia and diabetic neuropathy
por: Wright, Alan, et al.
Publicado: (2010)

Typology of patients with fibromyalgia: cluster analysis of duloxetine study patients
por: Lipkovich, Ilya A, et al.
Publicado: (2014)

Duloxetine for fibromyalgia syndrome: a systematic review and meta-analysis
por: Migliorini, Filippo, et al.
Publicado: (2023)

Duloxetine: A Review of Its Safety and Efficacy in the Management of Fibromyalgia Syndrome
por: Smith, Howard S., et al.
Publicado: (2010)

Variations in the management of fibromyalgia by physician specialty: rheumatology versus primary care
por: Able, Stephen L, et al.
Publicado: (2016)

Biology and therapy of fibromyalgia. New therapies in fibromyalgia
por: Arnold, Lesley M
Publicado: (2006)

Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials
por: Sultan, Asquad, et al.
Publicado: (2008)

The reliability and validity of The Turkish version of Multidimensional Fatigue Inventory-20 for the evaluation of different dimensions of fatigue in patients with fibromyalgia
por: Başoğlu, Fatma, et al.
Publicado: (2020)

Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia
por: Peng, X, et al.
Publicado: (2014)

Patterns of health care utilization related to initiation of amitriptyline, duloxetine, gabapentin, or pregabalin in fibromyalgia
por: Kim, Seoyoung C, et al.
Publicado: (2015)

Results of switching to milnacipran in fibromyalgia patients with an inadequate response to duloxetine: a phase IV pilot study
por: Bateman, Lucinda, et al.
Publicado: (2013)

Comparing common reasons for inpatient and outpatient visits between commercially-insured duloxetine or pregabalin initiators with fibromyalgia
por: Zhao, Yang, et al.
Publicado: (2012)

Parkinsonism secondary to duloxetine use: a case report
por: Bayrak, Arzu, et al.
Publicado: (2015)

Saffron (Crocus sativus) versus duloxetine for treatment of patients with fibromyalgia: A randomized double-blind clinical trial
por: Shakiba, Mansoor, et al.
Publicado: (2018)

Functional bowel symptoms, fibromyalgia and fatigue: A food-induced triad?
por: Berstad, Arnold, et al.
Publicado: (2012)

Duloxetine in the treatment of major depressive disorder: an open-label study
por: Hudson, James I, et al.
Publicado: (2007)

Duloxetine induced hyponatremia
por: Kulkarni, M.
Publicado: (2015)

Priapism and renal colic in a patient treated with duloxetine
por: Wilkening, G. Lucy, et al.
Publicado: (2016)

Fatigue Profiles in Patients with Multiple Sclerosis are Based on Severity of Fatigue and not on Dimensions of Fatigue
por: Beckerman, Heleen, et al.
Publicado: (2020)

Impact of potential pregabalin or duloxetine drug–drug interactions on health care costs and utilization among Medicare members with fibromyalgia
por: Ellis, Jeffrey J, et al.
Publicado: (2014)

Beyond pain in fibromyalgia: insights into the symptom of fatigue
por: Vincent, Ann, et al.
Publicado: (2013)

Assessment of sleep in patients with fibromyalgia: qualitative development of the fibromyalgia sleep diary
por: Kleinman, Leah, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_49qeo2obuc2sbo2f73ej109os3